--- title: "蔡司視力保健與醫療眼鏡中心達成戰略合作伙伴關係，將光學卓越與以患者為中心的運營系統相結合" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/277677287.md" description: "蔡司視覺護理與醫療眼鏡中心（MEC）建立了戰略合作伙伴關係，以提升光學護理和患者體驗。此次多年協議指定 MEC 為蔡司的獨家光學配鏡管理組織，提供先進鏡片創新和運營支持。此次合作旨在將光學配鏡服務整合到臨牀護理中，提高患者滿意度，並推動獨立眼科診所的增長。兩家公司強調對臨牀卓越和運營效率的承諾，為光學護理服務設定了新的標準" datetime: "2026-03-03T20:38:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277677287.md) - [en](https://longbridge.com/en/news/277677287.md) - [zh-HK](https://longbridge.com/zh-HK/news/277677287.md) --- # 蔡司視力保健與醫療眼鏡中心達成戰略合作伙伴關係，將光學卓越與以患者為中心的運營系統相結合 The multi-year agreement gives MEC practices access to the latest lens innovation and industry-leading manufacturing services from ZEISS HEBRON, Ky.--(BUSINESS WIRE)-- ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, today announced a strategic partnership with Medical Eyeglass Center (MEC), a nationally recognized, full-service optical dispensary management organization. The collaboration establishes ZEISS as the exclusive laboratory and service provider within MEC’s optical dispensary management organization. MEC will serve as the exclusive optical dispensary management organization aligned with ZEISS within participating practices. This partnership brings together ZEISS’ industry-leading lens innovation and MEC’s proven, data-driven dispensary management model to help independent eye care practices elevate optical care, enhance patient experience, and unlock new levels of performance. This collaboration enables practices to build optical dispensaries that function as dynamic extensions of clinical care, delivering best-corrected vision through a fully integrated optical dispensary model. “At ZEISS, we are driven by a commitment to precision, innovation, and better vision for every patient,” said Gary Rosenblum, President and CEO of ZEISS Vision Care US. “Partnering with MEC allows us to further extend that commitment beyond the dispensary and into the full patient journey. MEC’s operational expertise and analytics capabilities empower practices to deliver a premium, seamless optical experience that matches the quality of their clinical care.” With over four decades of experience, MEC has built a reputation for helping practices design, launch, and optimize high-performing optical dispensaries. Its comprehensive model integrates directly into practice workflows and includes inventory strategy, vendor management, staff development, and continuous operational support. The result is a turnkey system that strengthens capture rates, improves patient satisfaction, and drives sustainable growth. **Participating independent eye care practices will gain access to:** - Structured, turnkey optical development and operational support - Advanced performance reporting and actionable analytics - Seamless patient flow from exam room to eyewear delivery - Strategic inventory planning and vendor management - ZEISS lens innovation and technology “This is more than a partnership—it’s a powerful alignment of clinical excellence and operational execution,” said Rob Katz, CEO and Owner of Medical Eyeglass Center. “MEC’s role is to actively manage and execute alongside practices, not simply advise from the sidelines. Together with ZEISS, we are delivering a unified platform that connects leading global optical innovation with real-world systems that drive results.” The collaboration underscores a shared commitment to advancing and strengthening independent eye care practitioners, increasing provider confidence in optical recommendations and delivering a consistently elevated patient experience. Together, ZEISS and MEC are setting a new standard for how optical care is delivered, managed, and experienced. **About ZEISS** ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totalling almost 12 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets (September 30, 2025). For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses, and binoculars. With a portfolio aligned with future growth areas like digitalization, healthcare, and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future. With over 46,600 employees, ZEISS is active globally in around 50 countries with more than 60 sales and service locations, around 40 research and development facilities, and 30 production facilities worldwide (September 30, 2025). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG. Further information at **www.zeiss.com** **ZEISS Vision Care** ZEISS Vision Care, part of ZEISS Consumer Markets segment, develops and manufactures comprehensive solutions for the entire value chain of ophthalmic optics. The portfolio includes top-quality eyeglass lenses, partner programs, ophthalmic instruments, services, digital solutions and apps for both eye care professionals and consumers, as well as care products for the eye and beyond. As one of the world's leading manufacturers of eyeglass lenses and the best-known prescription eyeglass lens brand amongst consumers worldwide, ZEISS is focused on optimal visual comfort and individualized vision solutions. With a passion for innovation and quality, ZEISS Vision Care is committed to protecting and enhancing people's vision and contributing to lifelong visual health. **About Medical Eyeglass Center** Medical Eyeglass Center is a U.S.-based, full-service optical dispensary management organization specializing in building, optimizing, and sustaining high-performance optical programs for eye care practices. Through data-driven strategy, seamless workflow integration, and ongoing operational support, MEC helps practices elevate patient experience and profitability. Learn more at: http://www.medicaleyeglass.net/ View source version on businesswire.com: https://www.businesswire.com/news/home/20260303106722/en/ Source: ZEISS Vision Care ### 相關股票 - [AFX.DE](https://longbridge.com/zh-HK/quote/AFX.DE.md) ## 相關資訊與研究 - [強化佈局台灣多元事業 蔡慧接任蔡司台灣總經理](https://longbridge.com/zh-HK/news/280154710.md) - [摩根大通給予卡爾蔡司醫療技術公司（0DHC）賣出評級](https://longbridge.com/zh-HK/news/286208300.md) - [特朗普表示，他希望霍爾木茲海峽保持開放和自由，並且不收取通行費](https://longbridge.com/zh-HK/news/287252246.md) - [Elis：披露截至2026年4月30日的資本構成股份數量及總投票權數量](https://longbridge.com/zh-HK/news/286770212.md) - [華爾街分析師是否預測 Brown-Forman 的股票將上漲還是下跌？](https://longbridge.com/zh-HK/news/286932286.md)